The effect of serotonin 5HT 1B receptor ligands on amphetamine self-administration in rats

European Journal of Pharmacology

Volumn 677, Issue 1-3, 2012, Pages 111-115

  Miszkiel, Joanna ^a   Adamczyk, Przemysław ^a   Filip, Małgorzata ^a   Przegaliński, Edmund ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

5 HT 1B receptor; Amphetamine self administration; Rat

Indexed keywords

5 PROPOXY 3 (1,2,5,6 TETRAHYDRO 4 PYRIDYL)PYRROLO[3,2 B]PYRIDINE; AMPHETAMINE; N [3 [3 (DIMETHYLAMINO)ETHOXY] 4 METHOXYPHENYL] 2' METHYL 4' (5 METHYL 1,2,4 OXADIAZOL 3 YL) [1,1' BIPHENYL] 4 CARBOXAMIDE; SB 216641; SEROTONIN 1B ANTAGONIST; UNCLASSIFIED DRUG; BENZAMIDE DERIVATIVE; LIGAND; N (3 (2 DIMETHYLAMINO)ETHOXY 4 METHOXYPHENYL) 2' METHYL 4' (5 METHYL 1,2,4 OXADIAZOL 3 YL) (1,1' BIPHENYL) 4 CARBOXAMIDE; N-(3-(2-DIMETHYLAMINO)ETHOXY-4-METHOXYPHENYL)-2'-METHYL-4'-(5-METHYL-1,2,4-OXADIAZOL-3-YL)-(1,1'-BIPHENYL)-4-CARBOXAMIDE; OXADIAZOLE DERIVATIVE; PYRIDINE DERIVATIVE; SEROTONIN 1 AGONIST; SEROTONIN 1 ANTAGONIST; SEROTONIN 1B RECEPTOR;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DEPENDENCE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG SELECTIVITY; DRUG SELF ADMINISTRATION; LIGAND BINDING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; ANIMAL; DRUG EFFECT; METABOLISM; WISTAR RAT;

AMPHETAMINE; ANIMALS; BEHAVIOR, ANIMAL; BENZAMIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; LIGANDS; MALE; OXADIAZOLES; PYRIDINES; RATS; RATS, WISTAR; RECEPTOR, SEROTONIN, 5-HT1B; SEROTONIN 5-HT1 RECEPTOR AGONISTS; SEROTONIN 5-HT1 RECEPTOR ANTAGONISTS;

EID: 84856250409     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2011.12.033     Document Type: Article

References (45)

1. S.G. Amara, and M.S. Sonders Neurotransmitter transporters as molecular targets for addictive drugs Drug Alcohol Depend. 51 1998 87 96 (Pubitemid 28353758)
2. N.M. Barnes, and T. Sharp A review of central 5-HT receptors and their function Neuropharmacology 38 1999 1083 1152 (Pubitemid 29292403)
3. S. Benloucif, M.J. Keegan, and M.P. Galloway Serotonin-facilitated dopamine release in vivo: pharmacological characterization J. Pharmacol. Exp. Ther. 265 1993 373 377 (Pubitemid 23320984)
4. 1B knockout mice: effects of injection route on acute and sensitized responses Behav. Pharmacol. 12 2001 549 555 (Pubitemid 33152280)
5. M.E. Cain, C.M. Smith, and M.T. Bardo The effect of novelty on amphetamine self-administration in rats classified as high and low responders Psychopharmacology 176 2004 129 138 (Pubitemid 39517942)
6. M.E. Cain, E.D. Denehy, and M.T. Bardo Individual differences in amphetamine self-administration: the role of the central nucleus of the amygdala Neuropsychopharmacology 33 2008 1149 1161 (Pubitemid 351367536)
7. M. Filip, E. Nowak, I. Papla, and E. Przegaliński Role of 5-hydroxytryptamine1B receptors and 5-hydroxytryptamine uptake inhibition in the cocaine-evoked discriminative stimulus effects in rats J. Physiol. Pharmacol. 52 2001 249 263 (Pubitemid 32613039)
8. M. Filip, M. Frankowska, M. Zaniewska, A. Gołda, and E. Przegaliński The serotonergic system and its role in cocaine addiction Pharmacol Rep. 57 2005 685 700
9. A.E. Fleckenstein, T.J. Volz, E.L. Riddle, J.W. Gibb, and G.R. Hanson New insights into the mechanism of action of amphetamines Annu. Rev. Pharmacol. Toxicol. 47 2007 681 698
10. P.J. Fletcher, and K.M. Korth RU-24969 disrupts d-amphetamine self-administration and responding for conditioned reward via stimulation of 5-HT1B receptors Behav. Pharmacol. 10 1999 183 193 (Pubitemid 29150038)
11. 1B receptors in the nucleus accumbens reduces self-administration of amphetamine on a progressive ratio schedule Pharmacol. Biochem. Behav. 71 2002 717 725 (Pubitemid 34219222)
12. 6 receptor antagonism potentiates the behavioral and neurochemical effects of amphetamine but not cocaine Neuropharmacology 42 2002 170 180 (Pubitemid 34137020)
13. 1B receptors causes hypothermia in the guinea pig Eur. J. Pharmacol. 331 1997 169 174 (Pubitemid 27331446)
14. K.P. Hill, and M. Sofuoglu Biological treatments for amphetamine dependence: recent progress CNS Drugs 21 2007 851 869 (Pubitemid 47443305)
15. S. Hjorth, and R. Tao The putative 5-HT1B receptor agonist CP-93,129 suppresses rat hippocampal 5-HT release in vivo: comparison with RU 24969 Eur. J. Pharmacol. 209 1991 249 252
16. R. Karler, L.D. Calder, and J.B. Bedingfield A novel nicotinic- cholinergic role in behavioral sensitization to amphetamine-induced stereotypy in mice Brain Res. 725 1996 192 198 (Pubitemid 27377781)
17. J.E. Klebaur, R.A. Bevins, T.M. Segar, and M.T. Bardo Individual differences in behavioral responses to novelty and amphetamine self-administration in male and female rats Behav. Pharmacol. 12 2001 267 275 (Pubitemid 32730508)
18. 1B receptor agonist, CP-94,253 Drug Dev. Res. 26 1992 241 250
19. M.J. Kuhar, M.C. Ritz, and J.W. Boja The dopamine hypothesis of the reinforcing properties of cocaine Trends Neurosci. 14 1991 299 302
20. A.P. Leccese, and W.H. Lyness The effects of putative 5-hydroxytryptamine receptor active agents on d-amphetamine self-administration in controls and rats with 5,7-dihydroxytryptamine median forebrain bundle lesions Brain Res. 303 1984 153 162 (Pubitemid 14122517)
21. W.H. Lyness, N.M. Friedle, and K.E. Moore Increased self-administration of d-amphetamine after destruction of 5-hydroxytryptaminergic neurons Pharmacol. Biochem. Behav. 12 1980 937 941 (Pubitemid 10039682)
22. 1A receptor antagonist reversed reward deficits observed during amphetamine withdrawal in rats Psychopharmacology (Berl) 178 2005 133 142 (Pubitemid 40379207)
23. 1B auto- and heteroreceptors Mol. Pharmacol. 58 2000 1271 1278
24. 1B receptor ligands on the amphetamine-induced locomotor hyperactivity in rats Pol. J. Pharmacol. 54 2002 351 357
25. L.H. Parsons, and J.B. Justice Jr. Perfusate serotonin increases extracellular dopamine in the nucleus accumbens as measured by in vivo microdialysis Brain Res. 606 1993 195 199 (Pubitemid 23098366)
26. L.H. Parsons, F. Weiss, and G.F. Koob Serotonin1B receptor stimulation enhances cocaine reinforcement J. Neurosci. 18 1998 10078 10089 (Pubitemid 28543782)
27. 1B/1A receptor agonist, potentiates cocaine-induced increases in nucleus accumbens dopamine Synapse 32 1999 132 135 (Pubitemid 29230142)
28. G.W. Price, M.J. Burton, L.J. Collin, M. Duckworth, L. Gaster, M. Göthert, B.J. Jones, C.J. Roberts, M. Watson, and D.N. Middlemiss SB-216641 and BRL-15572 -compounds to pharmacologically discriminate h5-HT1B and h5-HT1D receptors Naunyn-Schmiedeberg's Arch. Pharmacol. 356 1997 312 320 (Pubitemid 27376461)
29. 1B receptors in the sensitization to amphetamine in mice Eur. J. Pharmacol. 422 2001 91 99 (Pubitemid 32595580)
30. E. Przegaliński, M. Filip, I. Papla, and J. Siwanowicz Effect of serotonin (5-HT)1B receptor ligands on cocaine sensitization in rats Behav. Pharmacol. 12 2001 109 116 (Pubitemid 32458122)
31. 1B receptor ligands, microinjected into the accumbal shell or core on the sensitization to cocaine in rats Eur. Neuropsychopharmacol. 12 2002 387 396
32. 1B receptor ligands on the cocaine- and food-maintained self-administration in rats Eur. J. Pharmacol. 559 2007 165 172
33. R.B. Rothman, and M.H. Baumann Monoamine transporters and psychostimulant drugs Eur. J. Pharmacol. 479 2003 23 40 (Pubitemid 37377873)
34. H. Saito, M. Matsumoto, H. Togashi, and M. Yoshioka Functional interaction between serotonin and other neuronal systems: focus on in vivo microdialysis studies Jpn. J. Pharmacol. 70 1996 203 205
35. 1B auto and heteroreceptors Naunyn-Schmiedeberg's Arch. Pharmacol. 360 1999 382 390 (Pubitemid 29502986)
36. 3H]dopamine from rat striatal synaptosomes Naunyn-Schmiedeberg's Arch. Pharmacol. 359 1999 40 47 (Pubitemid 29142568)
37. C.A. Schad, J.B. Justice Jr., and S.G. Holtzman Naloxone reduces the neurochemical and behavioral effects of amphetamine but not those of cocaine Eur. J. Pharmacol. 275 1995 9 16
38. E. Schlicker, K. Fink, G.J. Molderings, G.W. Price, M. Duckworth, L. Gaster, D.N. Middlemiss, J. Zentner, J. Likungu, and M. Gothert Effects of selective h5-HT1B (SB-216641) and h5-HT1D (BRL-15572) receptor ligands on guinea-pig and human 5-HT auto- and heteroreceptors NaunynSchmiedeberg's Arch. Pharmacol. 356 1997 321 332
39. L.S. Seiden, K.E. Sabol, and G.A. Ricaurte Amphetamine: effects on catecholamine systems and behavior Annu. Rev. Pharmacol. Toxicol. 33 1993 639 677 (Pubitemid 23116021)
40. T. Sharp, S.R. Bramwell, and D.G. Grahame-Smith 5-HT1 agonists reduce 5-hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysis Br. J. Pharmacol. 96 1989 283 290 (Pubitemid 19045101)
41. D. Sulzer, T.K. Chen, Y.Y. Lau, H. Kristensen, S. Rayport, and A. Ewing Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport J. Neurosci. 15 1995 4102 4108
42. 1B receptor agonist and antagonists in animal models of anxiety and depression Behav. Pharmacol. 15 2004 523 534 (Pubitemid 40075900)
43. 1B receptor agonist CP 94253: a possible mechanism of action Eur. J. Pharmacol. 516 2005 46 50 (Pubitemid 40780118)
44. 1B receptors within the ventral tegmental area in regulation of mesolimbic dopaminergic neuronal activity via GABA mechanisms: a study with dual-probe microdialysis Brain Res. 1021 2004 82 91
45. D.S. Yu, F.L. Smith, D.G. Smith, and W.H. Lyness Fluoxetine-induced attenuation of amphetamine self-administration in rats Life Sci. 39 1986 1383 1388 (Pubitemid 16029739)